Menu
Enrolling by invitation NCT07525323

EMG ss AMG In Robotic/Laparoscopic Surgery

No phase Interventional Surgery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: AMG device, EMG.
Who it may be relevant to
Registry conditions: Surgery. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Impact Of Electromyography Vs Acceleromyography On The Management Of Neuromuscular Block During Robotic And Laparoscopic Surgery: A Randomized Controlled Trial

Overview

The purpose of this study is to compare the mean cumulative weight-based/time-corrected rocuronium dose administered in patients undergoing robotic- or laparoscopic- assisted surgery using either acceleromyography or electromyography.

Interventions

  • Device AMG device
    The anesthesia team will use an AMG device to monitor neuromuscular block
  • Device EMG
    The anesthesia team will use an EMG device to monitor neuromuscular block

Primary outcome measures

  • Cumulative rocuronium dose [Time frame: Perioperative/Periprocedural]
Secondary outcome measures (4)
  • Mean sugammadex dose [Time frame: Perioperative/Periprocedural]
  • Number of rocuronium administrations [Time frame: Perioperative/Periprocedural]
  • Frequency of placing a peripheral nerve stimulator [Time frame: Perioperative/Periprocedural]
  • Depth of neuromuscular block prior to sugammadex administration [Time frame: Perioperative/Periprocedural]

Eligibility criteria

Inclusion criteria

  • Age > or = 18 years old
  • Patients willing to participate and provide an integrated, informed consent
  • Patients undergoing elective laparoscopic- or robotic-assisted surgical procedures
  • Anticipated surgery duration < 300 minutes Exclusion Criteria
  • Patients with disorders, such as stroke, carpal tunnel syndrome, broken wrist with nerve damage, Dupuytren contracture, or any similar wrist injury.
  • Patients with systemic neuromuscular diseases such as myasthenia gravis.
  • Patients having surgery that would involve prepping the arm into the sterile field.
  • Patients with chronic kidney disease (eGFR <60).

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Other

Study locations

United States · 1 center
  • Mayo Clinic in Florida — Jacksonville

Identifiers

NCT: NCT07525323 · 25-014604

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗